A pharmaceutical company is conducting a Phase III clinical trial for a new drug. The trial involves thousands of patients across multiple sites. To ensure the integrity of the results, an independent data monitoring committee (DMC) is established. The DMC's primary role is to regularly review accumulated data from the ongoing trial, including adverse events and efficacy endpoints, and to make recommendations regarding its continuation, modification, or termination. Which ethical principle does the establishment of a DMC primarily uphold in this context?
- AAutonomy, by ensuring participants can withdraw at any time.
- BFidelity, by ensuring the research team adheres to the study protocol.
- CBeneficence and Non-maleficence, by protecting patient safety and maximizing benefits while minimizing harm.
- DJustice, by ensuring equitable distribution of research burdens and benefits.
Show answer & explanationAnswer & explanation
Correct answer: C. Beneficence and Non-maleficence, by protecting patient safety and maximizing benefits while minimizing harm.
The DMC's role in reviewing adverse events and efficacy data, and recommending changes or termination, directly serves to protect patient well-being (non-maleficence) and ensure that the trial is likely to yield benefits that outweigh risks (beneficence). They act as an independent safeguard for participants.
Why the other options are wrong
- A. Autonomy relates to informed consent and the right to withdraw, which is important but not the DMC's primary function.
- B. Fidelity relates to trustworthiness and loyalty, and while a DMC contributes to trust, its primary focus is on the safety and scientific validity of the trial, which falls under beneficence/non-maleficence.
- D. Justice relates to fair selection and distribution of benefits/burdens, not the real-time monitoring of safety and efficacy.
Data Monitoring Committee (DMC)
An independent group of experts that periodically reviews accumulated data from an ongoing clinical trial to ensure the safety of participants and the scientific integrity and validity of the trial. They make recommendations on whether to continue, modify, or stop the trial.
- Independent of the study investigators and sponsor.
- Reviews safety and efficacy data regularly.
- Makes recommendations regarding trial continuation, modification, or termination.
- Primarily upholds ethical principles of beneficence and non-maleficence.
Memory trick: Justice, Autonomy, Beneficence, Fidelity (JABF) Protect